Skip to main content

Poor start to vaccine rollout poses risks to recovery

A decline in GDP in Q1 now seems highly likely, but the bigger concern is that slow vaccination programmes and concerns about virus variants may delay the lifting of restrictions in Q2 and beyond. Meanwhile, we expect confirmation next week that GDP contracted in Q4, and we should learn more about January’s “inflation shock”.

Become a client to read more

This is premium content that requires an active Capital Economics subscription to view.

Already have an account?

You may already have access to this premium content as part of a paid subscription.

Sign in to read the content in full or get details of how you can access it

Register for free

Sign up for a free account to gain:

  • Unlock additional content
  • Register for Capital Economics events
  • Receive email updates and economist-curated newsletters
  • Request a free trial of our services


Get access